Arthritis Research UK announces the award of a special strategic grant to develop a M-PROM (Musculoskeletal Patient Reported Outcome Measure)
Arthritis Research UK is delighted to announce the award to further develop a musculoskeletal patient reported outcome measure (M-PROM) has been made to a collaborative initiative between the Primary Care Sciences Research Centre in Keele, led by Dr Jonathan Hill, and the Oxford University Nuffield Orthopaedic Trust, led by Professor Ray Fitzpatrick. This will be the first time the two research teams have worked together.
Patient reported outcome measures (PROMs) are a way of recording how people rate their own health status. They are of particular value in musculoskeletal conditions where few biomedical measures are available to assess the effect of a disease on a person’s health. For conditions such as these, PROMs can be an effective way of measuring health outcomes.
The research teams will develop a candidate instrument that means patients’ own feedback on progress about meaningful aspects of their health status can be used to monitor and evaluate clinical outcomes in different musculoskeletal care settings. Key stakeholders within the musculoskeletal community, including people living with musculoskeletal conditions and clinicians, researchers, service providers and commissioners, will determine whether the proposed set of questions are acceptable, feasible and applicable across general practice, physiotherapy, rheumatology and orthopaedic settings.
Work will begin on developing the instrument in October 2013, expected to complete phase one in June 2014.
Arthritis Research UK announces a special strategic grant award to develop the MSK calculator
Arthritis Research UK is delighted to announce a research award to Imperial College London, led by Dr Michael Soljak, to develop four population prevalence models for the online musculoskeletal (MSK) calculator.
As the Chief Medical Officer has recognised, MSK health conditions are a data poor area. There is not good data available about the numbers of people with MSK conditions such as osteoarthritis for use in local planning of health services. This means that arthritis sometimes gets ‘left off the table’ when health planners are considering long term conditions.
To address this ‘data gap’, Arthritis Research UK is developing a MSK calculator to provide local estimates of the numbers of people with musculoskeletal conditions for use in local Joint Strategic Needs Assessments (JSNA), which are developed through the forum of the Health and Wellbeing Boards. The first wave of data in the MSK calculator will look at four of the more common MSK conditions in England: osteoarthritis, rheumatoid arthritis, back pain and the high fracture risk model (owing to the underlying condition of osteoporosis). These will encompass prevalence, incidence, and condition specific risk factors.
Work has commenced on developing the prevalence model for osteoarthritis, and the team hope to have the online tool available by Summer 2014.